Primary Packaging · Secondary Packaging · Tertiary Packaging
Outsourced Pharma Packaging & Labeling Services
Outsourced Pharma Packaging & Labeling Services offer compliant, end-to-end packaging, labeling and tracking solutions, enabling pharma firms to focus on core R&D and manufacturing.
561910
Industry Overview
Outsourced Pharma Packaging & Labeling Services provide comprehensive solutions for the pharmaceutical industry, including primary, secondary, and tertiary packaging, labeling, serialization, and track and trace solutions. These services ensure compliance with stringent FDA and international standards, enhance patient safety, and optimize supply chain logistics. Major pharmaceutical firms, biotechnology companies, and medical device manufacturers utilize these specialized services to focus on core activities like drug research and manufacturing.
Industry Segments
Industry Segment | Overview | Products/Services | Key Players |
|---|---|---|---|
Primary Packaging | Direct containment of pharmaceutical products, ensuring product safety, stability, and sterility. Update (2024): Primary Packaging accounted for the highest share of more than 70% in the US pharmaceutical packaging market as of 2022, with blister packs, bottles, vials, ampoules, and sachets seeing rising demand due to increased pharmaceutical consumption. Strips & blister packaging specifically made up 33.5% of the primary packaging market.[3][4] | Blister packs, bottles, vials, ampoules, pre-filled syringes, sachets, strip packs | PCI Pharma Services, Sharp Packaging, Pharma Packaging Solutions, Legacy Pharmaceutical Packaging, Catalent, West Pharmaceutical Services, WestRock, Packaging Coordinators Inc., Amcor, AptarGroup, Berry Global, Gerresheimer, WestRock[3] |
Secondary Packaging | Encloses primary packages for branding, information, and additional protection. | Cartoning, shrink wrapping, overwrapping, multi-pack assembly, tamper-evident packaging | PCI Pharma Services, Sharp Packaging, Pharma Packaging Solutions, Legacy Pharmaceutical Packaging, Almac Group, CCL Industries |
Tertiary Packaging | Bulk packaging for safe transport and distribution of pharmaceuticals. | Palletization, case packing, stretch wrapping, bulk containers, shipping cartons, protective packaging | PCI Pharma Services, Sharp Packaging, DHL Supply Chain, AmerisourceBergen, Pharma Packaging Solutions |
Labeling Services | Application of regulatory, product, and safety information to packages. | Regulatory-compliant labeling, multi-language labels, booklet labels, variable data printing | PCI Pharma Services, Sharp Packaging, Pharma Packaging Solutions, Legacy Pharmaceutical Packaging, Multi-Color Corporation (MCC) |
Serialization & Track and Trace | Solutions to ensure product traceability and anti-counterfeiting compliance. | Serialization coding, aggregation, tamper-evident seals, data management, compliance reporting | PCI Pharma Services, Sharp Packaging, Pharma Packaging Solutions, TraceLink, Optel Group, Legacy Pharmaceutical Packaging |
Industry Market Size
The final estimated market size for the U.S. Outsourced Pharmaceutical Packaging and Labeling Services industry in 2025 is $732.6 million, based on the most recent and verifiable data from IBISWorld. The methodology involved selecting the only recent, U.S.-specific figure for outsourced services. The market size estimation includes primary and secondary packaging and labeling services by external providers, contract packaging for various drug types, and services such as bottling, blister packaging, labeling, and serialization for different drug forms.
Competitive Landscape
The Outsourced Pharma Packaging & Labeling Services industry in the United States is moderately fragmented. It consists of a mix of large, diversified contract packaging organizations and numerous mid-sized and niche providers. The market is influenced by high regulatory requirements, technological advancements, and a growing demand for integrated solutions. While a few large players hold significant market presence, a long tail of smaller firms caters to regional and specific segment needs. The unorganized segment, comprising smaller local providers, holds a modest share due to stringent compliance standards that favor established players.
Competitor | Primary Packaging | Secondary Packaging | Tertiary Packaging | Labeling Services | Serialization & Track and Trace |
|---|---|---|---|---|---|
Catalent, Inc. (NYSE: CTLT) | Yes | Yes | No | Yes | Yes |
WestRock Company (NYSE: WRK) | No | Yes | Yes | Yes | Yes |
Amcor plc | Yes | Yes | Yes | Yes | Yes |
BALL CORPORATION | Yes | Yes | No | No | No |
West Pharmaceutical Services Inc. | Yes | No | No | Yes | Yes |
Nipro Corporation | Yes | No | No | Yes | No |
Pfizer CentreOne | Yes | Yes | No | Yes | Yes |
PCI Pharma Services | Yes | Yes | Yes | Yes | Yes |
Sharp Packaging | Yes | Yes | Yes | Yes | Yes |
Aphena Pharma Solutions | Yes | Yes | No | Yes | Yes |
Thermo-Pak Co., Inc. | Yes | Yes | No | Yes | No |
Pharma Packaging Solutions | Yes | Yes | No | Yes | Yes |
Legacy Pharmaceutical Packaging | Yes | Yes | No | Yes | Yes |
Competitor SWOT
The SWOT analysis of outsourced pharma packaging and labeling services in the U.S. highlights strengths such as product leadership, operational excellence, and market leadership across companies like Amcor plc, Catalent, Inc., and West Pharmaceutical Services Inc. However, common weaknesses include high customer concentration and limited product diversification, while opportunities lie in market growth and technological advances, and threats include competitive pressures and regulatory risks.
Company Name | Strengths | Weaknesses | Opportunities | Threats |
|---|---|---|---|---|
Amcor plc | - Product leadership with innovative packaging solutions and strong patent portfolio. - Strong brand and customer loyalty. - Operational excellence and scalable supply chain. - Market leadership with significant U.S. market share. - Experienced leadership team. | - High customer concentration. - Above-average debt levels. - Limited product diversification. | - Market growth driven by e-commerce and sustainability trends. - Expansion into sustainable packaging solutions. - Strategic partnerships and M&A potential. - Technological advances in AI and IoT. | - Competitive pressures from established and new entrants. - Regulatory risks and economic sensitivity. - Technological disruption and currency risks. |
Catalent, Inc. | - Strong position in pharmaceutical and biotechnology sectors. - Market leadership in CDMO space. - Operational excellence and recurring revenue model. - Experienced leadership team. - High barriers to entry. | - High customer concentration. - High debt levels. - Regulatory challenges and limited product diversification. | - CDMO market growth. - Expansion into biologics and gene therapy. - Strategic partnerships and M&A potential. - Technological advances and regulatory opportunities. | - Competitive pressures and regulatory risks. - Economic sensitivity and technological disruption. - Reputation risks and currency fluctuations. |
Ball Corporation | - Leadership in sustainable aluminum packaging. - Strong brand and operational excellence. - Market leadership in beverage cans. - Experienced leadership team. - High barriers to entry. | - High customer concentration. - Elevated debt levels. - Limited product diversification. | - Market growth in sustainable packaging. - Untapped markets and new product opportunities. - Strategic partnerships and M&A potential. | - Competitive pressures and regulatory risks. - Economic sensitivity and technological disruption. - Reputation risks and geopolitical risks. |
Pfizer CentreOne | - Product leadership with proprietary technology. - Strong brand and operational excellence. - Market leadership in CDMO market. - Experienced leadership team. | - High customer concentration. - Limited product diversification. - Regulatory challenges and debt levels. | - CDMO market growth. - Expansion into biologics manufacturing. - Strategic partnerships and technological advances. | - Competitive pressures and regulatory risks. - Economic sensitivity and technological disruption. - Reputation risks and geopolitical risks. |
WestRock Company | - Innovative packaging solutions. - Market leadership post-merger. - Operational excellence and experienced leadership. - High barriers to entry. | - High customer concentration. - Debt management concerns. - Limited product diversification. | - Growth in sustainable packaging. - Expansion into digital printing and smart packaging. - Strategic partnerships and M&A potential. | - Competitive pressures and economic sensitivity. - Regulatory risks and technological disruption. |
Nipro Corporation | - Strong position in medical devices. - High customer loyalty and operational excellence. - Market leadership in dialysis products. - Recent U.S. expansion. | - High customer concentration. - Limited product diversification. - Debt levels and regulatory challenges. | - U.S. healthcare market growth. - Geographic expansion and new product opportunities. - Strategic partnerships and technological advances. | - Competitive pressures and regulatory risks. - Economic sensitivity and technological disruption. |
West Pharmaceutical Services Inc. | - Product leadership in drug delivery systems. - Strong brand and operational excellence. - Market leadership and recurring revenue model. - Experienced leadership team. | - High customer concentration. - Limited product diversification. - Debt levels and regulatory challenges. | - Pharmaceutical packaging market growth. - Geographic expansion and new product opportunities. - Strategic partnerships and technological advances. | - Competitive pressures and regulatory risks. - Economic sensitivity and technological disruption. |
Sharp Packaging | - Market position as a leading outsourced packager. - Operational excellence and specialized capabilities. - Production capacity expansion. - Experienced leadership team. | - High customer concentration. - Limited product diversification. - Debt levels and key employee dependency. | - U.S. pharmaceutical packaging market growth. - Sterile injectables and gene therapy packaging opportunities. - Strategic acquisitions and technological advances. | - Competitive pressures and regulatory risks. - Economic sensitivity and technological disruption. |
PCI Pharma Services | - Product leadership in pharmaceutical services. - Operational excellence and market leadership. - Experienced leadership team and high barriers to entry. | - High customer concentration. - Limited product diversification. - Debt levels and regulatory challenges. | - High potency market growth. - Geographic expansion and new product opportunities. - Strategic partnerships and technological advances. | - Competitive pressures and regulatory risks. - Economic sensitivity and technological disruption. |
Thermo-Pak Co., Inc. | - Product leadership in packaging solutions. - Strong brand and operational excellence. - Market leadership and recurring revenue model. - Experienced leadership team. | - High customer concentration. - Limited product diversification. - Debt levels and key employee dependency. | - U.S. packaging market growth. - Geographic expansion and new product opportunities. - Strategic partnerships and technological advances. | - Competitive pressures and regulatory risks. - Market saturation and economic sensitivity. |
Aphena Pharma Solutions | - Product leadership in pharmaceutical packaging. - Operational excellence and strategic locations. - Expansive capabilities and experienced leadership. | - High customer concentration. - Limited product diversification. - Debt levels. | - Pharmaceutical packaging industry growth. - Expansion capabilities and new product opportunities. - Strategic partnerships and technological advances. | - Competitive pressures and regulatory risks. - Economic sensitivity and technological disruption. |
Pharma Packaging Solutions | - Product leadership with proprietary technology. - Strong brand and operational excellence. - Experienced leadership team and high barriers to entry. | - High customer concentration. - Limited product diversification. - Debt levels and key employee dependency. | - U.S. pharmaceutical packaging market growth. - New product opportunities and strategic partnerships. - Technological advances and M&A potential. | - Competitive pressures and regulatory risks. - Economic sensitivity and technological disruption. |
Legacy Pharmaceutical Packaging | - Product leadership and operational excellence. - Market leadership and experienced leadership team. - Parent organization support. | - High customer concentration. - Limited product diversification. - Debt levels and regulatory challenges. | - Pharmaceutical packaging industry growth. - New product opportunities and strategic partnerships. - Technological advances and biopharmaceutical segment opportunities. | - Competitive pressures and regulatory risks. - Economic sensitivity and technological disruption. |
